Law360, New York (May 07, 2009, 12:00 AM ET) -- In a patent infringement suit brought by Infosint SA over the antidepressant citalopram, a federal judge has refused to limit Forest Laboratories Inc.'s liability through a law meant to protect "innocent infringers" before they know about a patent.
Judge Lewis A. Kaplan of the U.S. District Court for the Southern District of New York ruled Tuesday that genuine issues of fact remained on the question of whether Forest — which makes and sells the antidepressant as Celexa and Lexapro in the U.S. through license agreements with...
Forest Loses Bid To Limit Liability In Citalopram IP Suit
To view the full article, take a free trial now.
